HCA Healthcare Files 8-K on Financials and Operations
Ticker: HCA · Form: 8-K · Filed: Oct 25, 2024 · CIK: 860730
Sentiment: neutral
Topics: financial-condition, operations, disclosure
TL;DR
HCA Healthcare dropped an 8-K detailing financials & operations. Check it out.
AI Summary
HCA Healthcare, Inc. filed an 8-K on October 25, 2024, reporting on its results of operations and financial condition. The filing also includes disclosures related to Regulation FD and other events, along with financial statements and exhibits. The company is incorporated in Delaware and headquartered in Nashville, Tennessee.
Why It Matters
This 8-K filing provides investors with crucial updates on HCA Healthcare's financial performance and operational status, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine 8-K filing providing standard financial and operational updates, not indicating any immediate or significant new risks.
Key Players & Entities
- HCA Healthcare, Inc. (company) — Registrant
- October 25, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Nashville, Tennessee (location) — Principal Executive Office Location
FAQ
What is the primary purpose of this 8-K filing for HCA Healthcare, Inc.?
The primary purpose of this 8-K filing is to report on HCA Healthcare, Inc.'s results of operations and financial condition, as well as to provide disclosures related to Regulation FD and other events.
On what date was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on October 25, 2024.
In which U.S. state is HCA Healthcare, Inc. incorporated?
HCA Healthcare, Inc. is incorporated in Delaware.
What is the address of HCA Healthcare, Inc.'s principal executive offices?
The address of HCA Healthcare, Inc.'s principal executive offices is One Park Plaza, Nashville, Tennessee, 37203.
What other types of information are included in this 8-K filing besides financial results?
This 8-K filing also includes information on Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits.
Filing Stats: 522 words · 2 min read · ~2 pages · Grade level 9.6 · Accepted 2024-10-25 07:38:49
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value per share HCA New York St
- $0.66 — d declared a quarterly cash dividend of $0.66 per share of the Company's common stock
Filing Documents
- hca-20241025.htm (8-K) — 41KB
- hca-ex99_1.htm (EX-99.1) — 898KB
- img60930783_0.jpg (GRAPHIC) — 32KB
- 0000950170-24-117215.txt ( ) — 1132KB
- hca-20241025.xsd (EX-101.SCH) — 24KB
- hca-20241025_htm.xml (XML) — 5KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On October 25, 2024, HCA Healthcare, Inc. (the "Company") issued a press release announcing, among other matters, its results of operations for the third quarter ended September 30, 2024, the text of which is set forth as Exhibit 99.1 .
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. On October 25, 2024, the Company issued a press release announcing, among other matters, its results of operations for the third quarter ended September 30, 2024, the text of which is set forth as Exhibit 99.1 .
01. Other Events
Item 8.01. Other Events. On October 25, 2024, the Company announced that its Board of Directors had declared a quarterly cash dividend of $0.66 per share of the Company's common stock. The dividend will be paid on December 27, 2024 to stockholders of record at the close of business on December 13, 2024.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits: Exhibit 99.1 Press Release, dated October 25, 2024 Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HCA HEALTHCARE, INC. Date: October 25, 2024 By: /s/ Michael A. Marks Michael A. Marks Executive Vice President and Chief Financial Officer